ANITA HERRERA: Open Payments
NPI 1013295336 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $93 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $116 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
| Novo Nordisk Inc | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Biogen, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: PROCLAIM, FARXIGA, SPRAVATO, KISUNLA, DUPIXENT, ZURZUVAE, ETERNA, INCEPTIV.
Industry payments across TX — which companies pay providers there.
